Barinthus Bio Reports First Quarter 2025 Financial Results and Updates on Corporate Developments May 7, 2025 08:00AM
Barinthus Biotherapeutics (BRNS) Announces Strategic Focus in Immunology and Inflammation (I&I) and Provides a Financial Update Jan 10, 2025 08:04AM
Barinthus Bio Announces Strategic Focus in Immunology and Inflammation (I&I) and Provides a Financial Update Jan 10, 2025 08:00AM
Barinthus Bio Announces Strategic Focus in Immunology and Inflammation (I&I) and Provides a Financial Update Jan 10, 2025 08:00AM
Barinthus Biotherapeutics (BRNS) Announces Strategic Pipeline Prioritization Following Positive Interim Data from VTP-300 in Chronic Hepatitis B Virus Infections Jun 12, 2024 04:01PM


Jun 12, 2024 04:01PM Barinthus Bio Announces Strategic Pipeline Prioritization Following Positive Interim Data from VTP-300 in Chronic Hepatitis B Virus Infections